Paper Details
- Home
- Paper Details
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review.
Author: BansbackNick, DurandCaylib, EldomaMaysoon, HazlewoodGlen S, MarshallDeborah A
Original Abstract of the Article :
OBJECTIVE: To summarize patients' preferences for disease-modifying antirheumatic drug (DMARD) therapy in rheumatoid arthritis (RA). METHODS: We conducted a systematic review to identify English-language studies of adult patients with RA that measured patients' preferences for DMARD or health state...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.3899/jrheum.181165
データ提供:米国国立医学図書館(NLM)
DMARD Preferences in Rheumatoid Arthritis: A Patient-Centered Approach
This study dives into the fascinating world of patient preferences for disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA). It's like charting a course through a vast desert of treatment options, where individual needs and values must be carefully considered. The authors conducted a systematic review of studies that measured patient preferences for DMARDs, revealing the complex interplay between treatment benefits, risks, and personal considerations. Their findings emphasize the importance of individualizing treatment decisions to meet the unique needs of each patient.
Individualizing Treatment for Optimal Outcomes
This research reveals that patients with rheumatoid arthritis have varying preferences for DMARD treatments. Some prioritize disease improvement over potential side effects, while others prioritize minimizing risks. This study underscores the importance of open communication between patients and their physicians to ensure that treatment plans align with individual preferences and priorities. It's like finding the ideal path through the desert, where individual strengths and challenges are taken into account.
Empowering Patients with Choices
This research empowers patients to actively participate in their treatment decisions. It highlights the importance of considering individual preferences and priorities when choosing DMARDs. By understanding the factors that influence patient preferences, healthcare professionals can better tailor treatment plans to optimize outcomes and improve quality of life for individuals with RA.
Dr.Camel's Conclusion
This research, like a wise traveler navigating a vast desert of treatment options, emphasizes the importance of individualizing DMARD choices in rheumatoid arthritis. By considering patient preferences and priorities, we can create a more personalized and effective approach to treatment.
Date :
- Date Completed 2021-05-10
- Date Revised 2021-05-10
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.